Patent ID: 11957739
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  G

Claim 5:
6. The method of claim 1,
a) wherein the agent reduces the number of viable or proliferating cells in the cancer, and/or reduces the volume or size of a tumor comprising the cancer cells;
b) further comprising administering to the subject at least one additional therapeutic agent or regimen for treating the cancer;
c) wherein the agent is administered in a pharmaceutically acceptable formulation;
d) wherein the subject is an animal model of the cancer, optionally wherein the animal model is a mouse model; and/or
e) wherein the subject is a mammal, optionally wherein the mammal is a mouse or human, optionally wherein the mammal is a human.